V8Y — Quantum Healthcare Income Statement
0.000.00%
Last trade - 00:00- SG$21.48m
- SG$28.40m
- SG$12.69m
Annual income statement for Quantum Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 9.37 | 13.1 | 12.7 |
| Cost of Revenue | |||
| Gross Profit | 4.35 | 5.76 | 5.66 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 17.7 | 15.9 | 14.7 |
| Operating Profit | -8.33 | -2.79 | -2.06 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -8.78 | -3.28 | -2.52 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -8.9 | -3.38 | -2.56 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | -9.07 | -3.62 | -2.23 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -9.07 | -3.62 | -2.23 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.001 | -0 | -0 |